Age, years |
65.3±8.7 |
64.3±9.5 |
0.557 |
Female, n(%) |
17(40.5) |
67(39.9) |
0.944 |
BMI, kg/m2
|
23.7±2.8 |
23.8±3.1 |
0.910 |
Persistent AF, n(%) |
18(42.9) |
66(39.3) |
0.805 |
AF duration, years [M(P25, P75)] |
1.1(0.2-5.2) |
1.1(0.1-5.0) |
0.666 |
ALT, U/L [M(P25, P75)] |
21.5(17.0-31.8) |
21.0(14.0-31.0) |
0.441 |
Cr, umol/L [M(P25, P75)] |
78.7(70.6-87.6) |
77.8(65.4-89.8) |
0.747 |
Hemoglobin, g/L |
140.6±17.4 |
142.5±18.2 |
0.549 |
QRS duration, ms [M(P25, P75)] |
157.0(122.0- 200.0) |
90.0(68.0-118.0) |
<0.001 |
Echocardiography |
|
|
|
LAD, mm (\(\overset{\overline{}}{x}\)±s) |
39.7±5.1 |
39.3±5.7 |
0.711 |
LVEF, % (\(\overset{\overline{}}{x}\)±s) |
50.9±12.9 |
51.4±12.7 |
0.793 |
LVEDD, mm (\(\overset{\overline{}}{x}\)±s) |
52.3±5.5 |
52.3±6.6 |
0.997 |
Concomitant disease |
|
|
|
Heart failure, n(%) |
8(19.0) |
32(19.0) |
1.000 |
Coronary artery disease, n(%) |
16(38.1) |
57(33.9) |
0.744 |
Hypertension, n(%) |
20(47.6) |
81(48.2) |
1.000 |
Diabetes Mellitus, n(%) |
8(19.0) |
30(17.9) |
1.000 |
Ischemic stroke, n(%) |
2(4.8) |
5(3.0) |
0.923 |
COPD, n(%) |
3(7.1) |
5(3.0) |
0.417 |
Medication |
|
|
|
ACEI/ARBs, n (%) |
15(35.7) |
57(33.9) |
0.827 |
Statins, n (%) |
10(23.8) |
46(27.4) |
0.640 |
β-blockers, n (%) |
17(40.5) |
49(29.2) |
0.158 |
CHA2DS2-VASc score |
2.3±1.6 |
2.2±1.5 |
0.779 |